← Back to directory
SB
Samsara BioCapital
Palo Alto, California, USAWebsite ↗
Samsara BioCapital is a venture capital firm founded in 2016 that invests in the life sciences sector, aiming to transform scientific advancements into impactful therapies for patients with unmet medical needs. The firm emphasizes a collaborative, patient-first approach, working closely with entrepreneurs to build leading companies across various stages of development.
Last raised
Oct 2025
10 mo ago
Latest fund size
$98M
opportunity fund
AUM
$1B
estimated
Funds raised
Capital this firm has raised, newest first
Samsara BioCapital
Unknown
$310M
opportunity fund
Oct 2025
$98M
Recent investments
Companies this firm has funded, newest first
| Company | Round | Amount | Date | Source |
|---|---|---|---|---|
| Abivax SA | — | — | Unknown | |
| LENZ Therapeutics, Inc. | — | — | Unknown | |
| Enlaza Therapeutics, Inc. | — | — | Unknown | |
| Dewpoint Therapeutics, Inc. | — | — | Unknown | |
| Nura Bio | Series B | — | Jun 2026 | |
| Memento Medicines | — | — | Jun 2026 | |
| Contineum Therapeutics | — | — | Mar 2026 | |
| Alamar Biosciences, Inc. | Series C | — | Jan 2026 |
Sources
Where this data came from